BACKGROUND: Measurement of biomarkers has been incorporated within clinical research
studies of asthma to characterize the population and associate the disease with …

Background Previous systematic reviews have not shown clear benefit of glucocorticoids for
acute viral bronchiolitis, but their use remains considerable. Recent large trials add …

Background Short-term targeted treatment can potentially prevent fall asthma exacerbations
while limiting therapy exposure. Objective We sought to compare (1) omalizumab with …

Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in
patients with chronic obstructive pulmonary disease (COPD). It is unclear whether the risk of …

BACKGROUND:: Systemic corticosteroids are known to increase diabetes risk, but the
effects of high-dose inhaled corticosteroids are unknown. We assessed whether the use and …

Asthma is a complex disease of the respiratory tract associated with chronic inflammation in
which an intricate network of cells and cellular factors plays a major role. Asthma is one of …

Rationale: The initial management of patients who present with persistent respiratory
symptoms includes recognizing those with the potential to benefit from inhaled steroid …

Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is
highly effective for both acute and chronic diseases, but evidence indicates that …

The pharmacokinetic and pharmacodynamic effects of inhaled corticosteroids (ICS) have
shaped the efficacy and safety of these agents in the treatment of asthma. Important …

Glucocorticoids remain a cornerstone of guideline-based management of persistent asthma
and allergic diseases. Glucocorticoid-induced osteoporosis (GIO) is the most common …